CPB Ljubljana 2018 course book

COMPARISON WITH BOOST TRIAL

Age and dose

<50 años

13.1%

11.4%

≤ 50 years old

11.9%

Positive margin Boost HDR

close or positive margins Boost HDR

>=50 años

4.6%

5.3%

> 50 years old

3.2%

Jones HA et al J Clin Oncol 2009;27:4939-47